• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者与临床试验的自动匹配:一种面向儿科白血病患者的自然语言处理方法。

Automated Matching of Patients to Clinical Trials: A Patient-Centric Natural Language Processing Approach for Pediatric Leukemia.

机构信息

Emergency Medicine Residency, Denver Health, Denver, CO.

Department of Pediatric Hematology/Oncology, Roger Maris Cancer Center, Sanford Health, Fargo, ND.

出版信息

JCO Clin Cancer Inform. 2023 Jul;7:e2300009. doi: 10.1200/CCI.23.00009.

DOI:10.1200/CCI.23.00009
PMID:37428994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10857751/
Abstract

PURPOSE

Matching patients to clinical trials is cumbersome and costly. Attempts have been made to automate the matching process; however, most have used a trial-centric approach, which focuses on a single trial. In this study, we developed a patient-centric matching tool that matches patient-specific demographic and clinical information with free-text clinical trial inclusion and exclusion criteria extracted using natural language processing to return a list of relevant clinical trials ordered by the patient's likelihood of eligibility.

MATERIALS AND METHODS

Records from pediatric leukemia clinical trials were downloaded from ClinicalTrials.gov. Regular expressions were used to discretize and extract individual trial criteria. A multilabel support vector machine (SVM) was trained to classify sentence embeddings of criteria into relevant clinical categories. Labeled criteria were parsed using regular expressions to extract numbers, comparators, and relationships. In the validation phase, a patient-trial match score was generated for each trial and returned in the form of a ranked list for each patient.

RESULTS

In total, 5,251 discretized criteria were extracted from 216 protocols. The most frequent criterion was previous chemotherapy/biologics (17%). The multilabel SVM demonstrated a pooled accuracy of 75%. The text processing pipeline was able to automatically extract 68% of eligibility criteria rules, as compared with 80% in a manual version of the tool. Automated matching was accomplished in approximately 4 seconds, as compared with several hours using manual derivation.

CONCLUSION

To our knowledge, this project represents the first open-source attempt to generate a patient-centric clinical trial matching tool. The tool demonstrated acceptable performance when compared with a manual version, and it has potential to save time and money when matching patients to trials.

摘要

目的

将患者与临床试验匹配既繁琐又昂贵。人们已经尝试过使匹配过程自动化;然而,大多数尝试都采用了以试验为中心的方法,该方法侧重于单个试验。在这项研究中,我们开发了一种以患者为中心的匹配工具,该工具将患者特定的人口统计学和临床信息与使用自然语言处理提取的包含和排除标准的自由文本临床试验进行匹配,以返回按患者资格可能性排序的相关临床试验列表。

材料和方法

从 ClinicalTrials.gov 下载了儿科白血病临床试验记录。使用正则表达式将各个试验标准离散化并提取出来。训练了一个多标签支持向量机(SVM)来将标准的句子嵌入分类为相关的临床类别。使用正则表达式解析标记标准,以提取数字、比较器和关系。在验证阶段,为每个试验生成一个患者-试验匹配分数,并以每个患者的排名列表形式返回。

结果

从 216 个方案中提取了 5251 个离散标准。最常见的标准是既往化疗/生物制剂(17%)。多标签 SVM 的准确率为 75%。与工具的手动版本相比,文本处理管道能够自动提取 68%的资格标准规则,而手动版本为 80%。与手动推导相比,自动化匹配大约需要 4 秒,而手动推导则需要数小时。

结论

据我们所知,该项目代表了首次尝试开发以患者为中心的临床试验匹配工具的开源项目。与手动版本相比,该工具的性能可接受,并且在将患者与试验匹配时有可能节省时间和金钱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/a5e00b44d42b/cci-7-e2300009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/21bdc3887b70/cci-7-e2300009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/debc23d4725d/cci-7-e2300009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/6810e2048757/cci-7-e2300009-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/a5e00b44d42b/cci-7-e2300009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/21bdc3887b70/cci-7-e2300009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/debc23d4725d/cci-7-e2300009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/6810e2048757/cci-7-e2300009-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/10857751/a5e00b44d42b/cci-7-e2300009-g004.jpg

相似文献

1
Automated Matching of Patients to Clinical Trials: A Patient-Centric Natural Language Processing Approach for Pediatric Leukemia.患者与临床试验的自动匹配:一种面向儿科白血病患者的自然语言处理方法。
JCO Clin Cancer Inform. 2023 Jul;7:e2300009. doi: 10.1200/CCI.23.00009.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.提高试验患者匹配效率:针对儿科肿瘤患者的自动化临床试验资格预筛选
BMC Med Inform Decis Mak. 2015 Apr 14;15:28. doi: 10.1186/s12911-015-0149-3.
4
Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations.对临床试验中的入选标准进行自动分类,以促进针对特定患者群体的患者与试验匹配。
J Am Med Inform Assoc. 2017 Jul 1;24(4):781-787. doi: 10.1093/jamia/ocw176.
5
ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening.ClinicalTrials.gov作为半自动即时医疗试验资格筛查的数据源。
PLoS One. 2014 Oct 21;9(10):e111055. doi: 10.1371/journal.pone.0111055. eCollection 2014.
6
Automatic trial eligibility surveillance based on unstructured clinical data.基于非结构化临床数据的自动试验资格监测。
Int J Med Inform. 2019 Sep;129:13-19. doi: 10.1016/j.ijmedinf.2019.05.018. Epub 2019 May 23.
7
Textual inference for eligibility criteria resolution in clinical trials.用于解决临床试验中纳入标准的文本推理
J Biomed Inform. 2015 Dec;58 Suppl(Suppl):S211-S218. doi: 10.1016/j.jbi.2015.09.008. Epub 2015 Sep 14.
8
Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center.人工智能工具用于优化大型社区癌症中心临床试验的资格筛选。
JCO Clin Cancer Inform. 2020 Jan;4:50-59. doi: 10.1200/CCI.19.00079.
9
Supporting patient screening to identify suitable clinical trials.支持患者筛查以确定合适的临床试验。
Stud Health Technol Inform. 2014;205:823-7.
10
Semantic query generation from eligibility criteria in clinical trials.从临床试验的纳入标准生成语义查询。
AMIA Annu Symp Proc. 2007 Oct 11:1070.

引用本文的文献

1
Development and implementation of cancer clinical trial patient screening using an electronic medical record-integrated trial matching system.使用电子病历集成试验匹配系统进行癌症临床试验患者筛选的开发与实施。
BMJ Health Care Inform. 2025 Jul 16;32(1):e101295. doi: 10.1136/bmjhci-2024-101295.
2
Enhancing Patient-Trial Matching With Large Language Models: A Scoping Review of Emerging Applications and Approaches.利用大语言模型加强患者与试验匹配:新兴应用与方法的范围综述
JCO Clin Cancer Inform. 2025 Jun;9:e2500071. doi: 10.1200/CCI-25-00071. Epub 2025 Jun 9.
3
Embracing Generative Artificial Intelligence in Clinical Research and Beyond: Opportunities, Challenges, and Solutions.

本文引用的文献

1
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research.儿科癌症数据共享库:联合并普及儿童癌症研究数据。
JCO Clin Cancer Inform. 2021 Sep;5:1034-1043. doi: 10.1200/CCI.21.00075.
2
Evaluation of an artificial intelligence clinical trial matching system in Australian lung cancer patients.澳大利亚肺癌患者人工智能临床试验匹配系统的评估
JAMIA Open. 2020 May 1;3(2):209-215. doi: 10.1093/jamiaopen/ooaa002. eCollection 2020 Jul.
3
BEHRT: Transformer for Electronic Health Records.BEHRT:电子健康记录的转换器。
在临床研究及其他领域采用生成式人工智能:机遇、挑战与解决方案
JACC Adv. 2025 Mar;4(3):101593. doi: 10.1016/j.jacadv.2025.101593. Epub 2025 Feb 8.
4
Implementation of a rule-based algorithm to find patients eligible for cancer clinical trials.实施一种基于规则的算法,以找出符合癌症临床试验条件的患者。
JAMIA Open. 2024 Nov 18;7(4):ooae131. doi: 10.1093/jamiaopen/ooae131. eCollection 2024 Dec.
5
Applying Artificial Intelligence in Pediatric Clinical Trials: Potential Impacts and Obstacles.人工智能在儿科临床试验中的应用:潜在影响与障碍
J Pediatr Pharmacol Ther. 2024 Jun;29(3):336-340. doi: 10.5863/1551-6776-29.3.336. Epub 2024 Jun 10.
Sci Rep. 2020 Apr 28;10(1):7155. doi: 10.1038/s41598-020-62922-y.
4
Improving Clinical Trial Participant Prescreening With Artificial Intelligence (AI): A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials.利用人工智能(AI)改进临床试验参与者的预筛选:3 项肿瘤学试验中 AI 辅助与标准方法结果的比较。
Ther Innov Regul Sci. 2020 Jan;54(1):69-74. doi: 10.1007/s43441-019-00030-4. Epub 2020 Jan 6.
5
Artificial Intelligence for Clinical Trial Design.人工智能在临床试验设计中的应用。
Trends Pharmacol Sci. 2019 Aug;40(8):577-591. doi: 10.1016/j.tips.2019.05.005. Epub 2019 Jul 17.
6
Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative.临床试验招募规划:来自临床试验转型倡议的一个拟议框架
Contemp Clin Trials. 2018 Mar;66:74-79. doi: 10.1016/j.cct.2018.01.003. Epub 2018 Jan 9.
7
Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.提高试验患者匹配效率:针对儿科肿瘤患者的自动化临床试验资格预筛选
BMC Med Inform Decis Mak. 2015 Apr 14;15:28. doi: 10.1186/s12911-015-0149-3.
8
Efficacy and safety concerns are important reasons why the FDA requires multiple reviews before approval of new drugs.疗效和安全性问题是美国食品药品监督管理局(FDA)在批准新药之前要求进行多次审评的重要原因。
Health Aff (Millwood). 2015 Apr;34(4):681-8. doi: 10.1377/hlthaff.2014.1160.
9
Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department.自动化临床试验资格预筛查:提高急诊科临床试验患者识别效率
J Am Med Inform Assoc. 2015 Jan;22(1):166-78. doi: 10.1136/amiajnl-2014-002887. Epub 2014 Jul 16.
10
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.科学和监管原因导致新药首次申请延迟和被 FDA 否决,2000-2012 年。
JAMA. 2014;311(4):378-84. doi: 10.1001/jama.2013.282542.